Compounding pharmacies continue to receive citations from the FDA (both Form FDA 483s and Warning Letters) for a continuing failure to meet 21 CFR 210/211 requirements.  All one needs to do is visit FDA’s Electronic Reading Room to learn of the ORA audits and the subsequent citations.  Even after the New England Compounding Center … [Read more...]